XTrackers MSCI USA Health Care UCITS ETF 1D

Issuer: Xtrackers

Asset Class: Equity

TER: 12bps

Trading Currency: GBX

Pays Income: False

Listing Date: 20 Apr 2018

Ticker: XSHC

ISIN: IE00BCHWNW54

This investment product provides targeted exposure to the U.S. healthcare sector, an area renowned for its blend of defensive qualities and significant long-term growth potential. The sector's resilience stems from the non-discretionary nature of healthcare spending, which tends to remain stable even during economic downturns. Growth is propelled by powerful secular trends, including an aging population in developed nations, continuous advancements in medical technology and biotechnology, and rising global healthcare expenditures. By investing in a basket of leading U.S. healthcare companies, investors can participate in the ongoing innovation within pharmaceuticals, medical devices, and healthcare services, positioning their portfolio to benefit from these durable, long-term drivers.

The fund tracks a market-cap-weighted index of U.S. large and mid-capitalisation stocks within the healthcare industry. This methodology provides diversified exposure across the entire sector value chain, from major pharmaceutical corporations with established drug pipelines and global distribution networks to innovative biotechnology firms at the forefront of genetic research and cutting-edge therapies. It also includes manufacturers of essential medical equipment and providers of crucial healthcare services. This diversification within the sector helps mitigate single-company risk while capturing the broad market performance of the industry's most significant players. The focus on the United States offers access to the world's largest and most dynamic healthcare market, home to a majority of the leading research and development firms.

Strategically, this product can serve as a valuable satellite holding within a well-diversified portfolio, offering a thematic tilt towards a sector with a compelling growth narrative. It is suitable for investors with a long-term investment horizon who are seeking to capitalize on the structural shifts shaping the future of medicine and wellness. The combination of defensive demand and innovative growth makes it an interesting consideration for those looking to enhance their portfolio's growth potential while maintaining a degree of resilience against market cyclicality.